SHED vs bmiMD: which GLP-1 program is better?
SHED and bmiMD are both telehealth GLP-1 programs, but they differ on price, medications, shipping and how you pay. Here's the side-by-side, with the numbers, so you can pick the right one.
Short answer: SHED is our pick in this matchup — a strong first-month discount on compounded GLP-1. Consider bmiMD instead if its strength — gLP-1 alongside a peptide and longevity menu, with ready-to-ship inventory — matters more to you.
Educational, not medical advice. This page explains GLP-1 medications in general terms. Only a licensed clinician who knows your history can decide what's right for you.
SHED is our pick in this matchup — a strong first-month discount on compounded GLP-1. Consider bmiMD instead if its strength — gLP-1 alongside a peptide and longevity menu, with ready-to-ship inventory — matters more to you.
View Plan: SHEDBest for: Strong intro discount
Choose SHED if…
you want SHED's edge — a strong first-month discount on compounded GLP-1.
Best for: GLP-1 telehealth
Choose bmiMD if…
you want bmiMD's edge — gLP-1 alongside a peptide and longevity menu, with ready-to-ship inventory.
Cost breakdown
The numbers that actually decide it, side by side.
| Starting price | 30% off first month (then plan rate) | $119/mo (compounded semaglutide) |
|---|---|---|
| Semaglutide | Compounded (plan-dependent) | $119/mo (compounded; list $228.60) |
| Tirzepatide | Compounded (plan-dependent) | Not a featured product |
| Offering | Compounded | Compounded |
| Shipping | Included | Included; 'Ready to Ship' in-stock inventory |
| Insurance | Cash | Cash |
On price, SHED lists Compounded (plan-dependent) for compounded semaglutide and Compounded (plan-dependent) for tirzepatide, while bmiMD lists $119/mo (compounded; list $228.60) and Not a featured product. Where prices are published, bmiMD is the lower-cost option.
Both are cash-pay compounded programs, so the real decision comes down to price, shipping, pharmacy credentials and support rather than the drug itself.
Full specs, side by side
| Why choose it | A strong first-month discount on compounded GLP-1 | GLP-1 alongside a peptide and longevity menu, with ready-to-ship inventory |
|---|---|---|
| Watch out for | Confirm the ongoing price after the intro month | Semaglutide starts at $119/mo — above the cheapest cash options; tirzepatide isn't featured |
| Starting price | 30% off first month (then plan rate) | $119/mo (compounded semaglutide) |
| Compounded semaglutide | Compounded (plan-dependent) | $119/mo (compounded; list $228.60) |
| Tirzepatide | Compounded (plan-dependent) | Not a featured product |
| GLP-1 + GIP option | Yes — compounded tirzepatide (GLP-1/GIP) | Not listed |
| Offering type | Compounded | Compounded |
| New-patient offer | 30% off first month | Sale pricing $119/mo (from $228.60) |
| Billing model | Monthly plan (intro discount month one) | Monthly plans |
| What's included | Medical evaluation, Medication, Shipping | Online medical evaluation, Medication, Shipping |
| Lab work | Online intake | Online intake |
| Shipping | Included | Included; 'Ready to Ship' in-stock inventory |
| Refills | Monthly refills | Monthly refills |
| States | Most US states | US telehealth |
| Pharmacy | US compounding pharmacies | US compounding pharmacies |
| Clinicians | US-licensed prescribers | US-licensed prescribers |
| Insurance | Cash | Cash |
| Consultation | Online medical intake | Online medical intake |
| Our rating | 9.2 · Excellent | 8.7 · Very Good |
Medications & formulations
- SHED: compounded GLP-1. Yes — compounded tirzepatide (GLP-1/GIP)
- bmiMD: compounded GLP-1. Not listed
New to the drugs themselves? Read our plain-language guides to semaglutide and tirzepatide.
Pros & cons
Pros
- Solid 30%-off intro offer
- Both semaglutide and tirzepatide
- Straightforward online process
Cons
- Ongoing price after intro month less transparent
- Compounded only
Pros
- Transparent list-vs-sale pricing shown upfront
- Ready-to-ship inventory for fast dispatch
- One clinic for GLP-1 plus peptide and longevity therapies
- No insurance required to start
Cons
- Compounded semaglutide entry ($119/mo) is higher than the cheapest cash programs
- Compounded tirzepatide isn't a featured option
- Compounded products aren't FDA-approved finished drugs
Where each one has the edge
We don't tally a winner — that hides the trade-offs. Here's who leads on each dimension and why.
SHED: Compounded (plan-dependent). bmiMD: $119/mo (compounded; list $228.60).
SHED offers compounded; bmiMD offers compounded.
SHED: Included. bmiMD: Included; 'Ready to Ship' in-stock inventory.
Comparable pharmacy disclosures.
Both are primarily cash-pay for compounded GLP-1.
Match by your priority
The fastest way to decide: find your top priority, see which program we'd point you to.
If your priority is the lowest published price
If your priority is the best shipping
If your priority is our overall pick
SHED vs bmiMD: common questions
The bottom line
SHED is our pick in this matchup — a strong first-month discount on compounded GLP-1. Choose bmiMD only if its strength (gLP-1 alongside a peptide and longevity menu, with ready-to-ship inventory) matters more to you than price and our overall rating.
How we compare — and how to read this
We compare programs on the factors that actually affect a patient: real price (including whether it's compounded or branded), medications and formulations offered, shipping, pharmacy accreditation and clinician model, insurance stance, and commitment. We name a top pick for most people, but we show the trade-offs in full so you can override it when your priorities or insurance point the other way. Pricing is provider-reported and changes frequently — and compounded-drug availability shifts with FDA shortage status — so always confirm the current details on the provider's own site before enrolling. Affiliate relationships do not change a program's placement. This page is educational and not medical advice; see our disclaimer.
Not sure which one is right for you?
Answer 7 quick questions and we'll match you to a program.
Take the match quiz